Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PG(40:3) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 9.2 | pmol/sample |
| - | PG(40:3) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 4.16 | pmol/sample |
| - | PG(40:3) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 4.02 | pmol/sample |
| - | PG(40:3) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 15.3 | pmol/sample |
| - | PG(40:3) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 15.3 | pmol/sample |
| - | PG(40:3) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 17.7 | pmol/sample |
| - | PG(40:3) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 3.4 | pmol/sample |
| - | PG(40:3) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 4.11 | pmol/sample |
| - | PG(40:3) | C | 0.0 | BCD100322A01 | 16.2 | pmol/sample |
| - | PG(40:3) | C | 0.5 | BCD100322A03 | 5.07 | pmol/sample |
| - | PG(40:3) | C | 1.0 | BCD100322A07 | 5.57 | pmol/sample |
| - | PG(40:3) | C | 2.0 | BCD100322A11 | 9.79 | pmol/sample |
| - | PG(40:3) | C | 4.0 | BCD100322A15 | 18.3 | pmol/sample |
| - | PG(40:3) | C | 8.0 | BCD100322A19 | 21.6 | pmol/sample |
| - | PG(40:3) | C | 12.0 | BCD100322A23 | 18.6 | pmol/sample |
| - | PG(40:3) | C | 24.0 | BCD100322A27 | 5.95 | pmol/sample |
| - | PG(40:3) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 3.28 | pmol/sample |
| - | PG(40:3) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 4.29 | pmol/sample |
| - | PG(40:3) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 8.62 | pmol/sample |
| - | PG(40:3) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 12.4 | pmol/sample |
| - | PG(40:3) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 15.6 | pmol/sample |
| - | PG(40:3) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 3.75 | pmol/sample |
| - | PG(40:3) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 3.65 | pmol/sample |
| - | PG(40:3) | 25OH-Chol | 0.5 | BCD100322A04 | 7.53 | pmol/sample |
| - | PG(40:3) | 25OH-Chol | 1.0 | BCD100322A08 | 3.41 | pmol/sample |
| - | PG(40:3) | 25OH-Chol | 2.0 | BCD100322A12 | 11.4 | pmol/sample |
| - | PG(40:3) | 25OH-Chol | 4.0 | BCD100322A16 | 11.8 | pmol/sample |
| - | PG(40:3) | 25OH-Chol | 8.0 | BCD100322A20 | 21.1 | pmol/sample |
| - | PG(40:3) | 25OH-Chol | 12.0 | BCD100322A24 | 18.2 | pmol/sample |
| - | PG(40:3) | 25OH-Chol | 24.0 | BCD100322A28 | 3.05 | pmol/sample |